Omni Star Financial Group, Inc. Neurocrine Biosciences Inc Transaction History

Omni Star Financial Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 06, 2020	SELL	$85.09 - $130.36 $280,797 - $430,188	-3,300 Closed	0 $0
Q1 2020 Apr 27, 2020	BUY	$75.11 - $113.76 $16,599 - $25,140	221 Added 7.18%	3,300 $286,000
Q4 2019 Jan 13, 2020	BUY	$86.8 - $118.57 $173 - $237	2 Added 0.06%	3,079 $331,000
Q3 2019 Oct 11, 2019	BUY	$83.82 - $101.5 $257,914 - $312,315	3,077 New	3,077 $277,000

622

95.2M

661K

221K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Omni Star Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Omni Star Financial Group, Inc. with notifications on news.